Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meyling Cheok

Showing results (21-30 of 50) with videos related to

Pageof 5
Sort By:
Blood Advances|October 27, 2020
Horizontal meta-analysis identifies common deregulated genes across AML subgroups providing a robust prognostic signatureAli Nehme, Hassan Dakik, Frédéric Picou, et al.
British Journal of Haematology|September 29, 2012
Genetic polymorphisms in ARID5B, CEBPE, IKZF1 and CDKN2A in relation with risk of acute lymphoblastic leukaemia in adults: a Group for Research on Adult Acute Lymphoblastic Leukaemia (GRAALL) studyPauline Peyrouze, Soizic Guihard, Nathalie Grardel, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 7, 2015
Defective NK Cells in Acute Myeloid Leukemia Patients at Diagnosis Are Associated with Blast Transcriptional Signatures of Immune EvasionZena Khaznadar, Nicolas Boissel, Sophie Agaugué, et al.
Cancer Research|July 3, 2008
Transporter-mediated protection against thiopurine-induced hematopoietic toxicityPartha Krishnamurthy, Matthias Schwab, Kazumasa Takenaka, et al.
Oncotarget|March 25, 2014
Clinical impact of gene mutations and lesions detected by SNP-array karyotyping in acute myeloid leukemia patients in the context of gemtuzumab ozogamicin treatment: results of the ALFA-0701 trialAline Renneville, Raouf Ben Abdelali, Sylvie Chevret, et al.
International Journal of Molecular Sciences|May 28, 2022
Involvement of ORAI1/SOCE in Human AML Cell Lines and Primary Cells According to ABCB1 Activity, LSC Compartment and Potential Resistance to Ara-C ExposureClara Lewuillon, Aurélie Guillemette, Sofia Titah, et al.
Leukemia|March 19, 2026
Targeting BMP and TAZ/TEAD mechanotransduction pathways impairs acute myeloid leukemia chemoresistanceLéa Barral, Nicolas Lespinasse, Camila Martin Cardozo, et al.
Journal of Experimental & Clinical Cancer Research : CR|January 8, 2026
Pre-therapeutic bone marrow-resident leukemic cells in acute myeloid leukemia exhibit a distinct dysregulated calcium signature and stem-like profile reflecting minimal residual disease precursorsSofia Titah, Aurélie Guillemette, Clara Lewuillon, et al.
Signal Transduction and Targeted Therapy|April 21, 2026
Surface CD81 supports leukemia stem cell function and reveals a therapeutic vulnerability in acute myeloid leukemiaFanny Gonzales, Pauline Peyrouze, Djohana Laurent, et al.
Cancers|September 11, 2019
Clinical Significance of ABCB1 in Acute Myeloid Leukemia: A Comprehensive StudyThomas Boyer, Fanny Gonzales, Adeline Barthélémy, et al.
Pageof 5

Showing results (21-30 of 50) with videos related to

Sort By:
Pageof 5
Blood Advances|October 27, 2020
Horizontal meta-analysis identifies common deregulated genes across AML subgroups providing a robust prognostic signatureAli Nehme, Hassan Dakik, Frédéric Picou, et al.
British Journal of Haematology|September 29, 2012
Genetic polymorphisms in ARID5B, CEBPE, IKZF1 and CDKN2A in relation with risk of acute lymphoblastic leukaemia in adults: a Group for Research on Adult Acute Lymphoblastic Leukaemia (GRAALL) studyPauline Peyrouze, Soizic Guihard, Nathalie Grardel, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 7, 2015
Defective NK Cells in Acute Myeloid Leukemia Patients at Diagnosis Are Associated with Blast Transcriptional Signatures of Immune EvasionZena Khaznadar, Nicolas Boissel, Sophie Agaugué, et al.
Cancer Research|July 3, 2008
Transporter-mediated protection against thiopurine-induced hematopoietic toxicityPartha Krishnamurthy, Matthias Schwab, Kazumasa Takenaka, et al.
Oncotarget|March 25, 2014
Clinical impact of gene mutations and lesions detected by SNP-array karyotyping in acute myeloid leukemia patients in the context of gemtuzumab ozogamicin treatment: results of the ALFA-0701 trialAline Renneville, Raouf Ben Abdelali, Sylvie Chevret, et al.
International Journal of Molecular Sciences|May 28, 2022
Involvement of ORAI1/SOCE in Human AML Cell Lines and Primary Cells According to ABCB1 Activity, LSC Compartment and Potential Resistance to Ara-C ExposureClara Lewuillon, Aurélie Guillemette, Sofia Titah, et al.
Leukemia|March 19, 2026
Targeting BMP and TAZ/TEAD mechanotransduction pathways impairs acute myeloid leukemia chemoresistanceLéa Barral, Nicolas Lespinasse, Camila Martin Cardozo, et al.
Journal of Experimental & Clinical Cancer Research : CR|January 8, 2026
Pre-therapeutic bone marrow-resident leukemic cells in acute myeloid leukemia exhibit a distinct dysregulated calcium signature and stem-like profile reflecting minimal residual disease precursorsSofia Titah, Aurélie Guillemette, Clara Lewuillon, et al.
Signal Transduction and Targeted Therapy|April 21, 2026
Surface CD81 supports leukemia stem cell function and reveals a therapeutic vulnerability in acute myeloid leukemiaFanny Gonzales, Pauline Peyrouze, Djohana Laurent, et al.
Cancers|September 11, 2019
Clinical Significance of ABCB1 in Acute Myeloid Leukemia: A Comprehensive StudyThomas Boyer, Fanny Gonzales, Adeline Barthélémy, et al.
Pageof 5